NCI Corner

Articles from the US National Cancer Institute about issues relevant to the field of thoracic oncology.

NCI Corner – Interview with Matthew Holderfield, PhD

NCI to Team Up with Cancer Research UK and the Cancer Research Technology Pioneer Fund on RAS Research On April 19, 2017, Cancer Research UK...

NCI Formulary Holds Promise to Speed Clinical Trials

By Erik T. MacLaren, PhD On January 11, the National Cancer Institute (NCI) launched a virtual agent formulary (NCI Formulary): a new public-private partnership designed...

NCI Corner – Interview with Shakun Malik, MD

By Erik J. Maclaren, PhD 2017 Mesothelioma Clinical Trials Planning Meeting Malignant mesothelioma is one of the most difficult cancers to control using existing therapies. Due...

Lung Cancer and Smoking Cessation: Opportunities for Progress

By Stephanie R. Land, PhD Tobacco cessation assistance, imperative for tobacco users who seek medical care,1 takes on even greater urgency for individuals who are...

NCI Corner – Interview with Dinah S. Singer, PHD

By Erik J. MacLaren, PhD Blue Ribbon Panel of the US National Cancer Advisory Board During his State of the Union address in January 2016, President...

Small Cell Lung Cancer: The Next Challenge

By Peter Ujhazy, MD, PhD The newfound optimism in the management of lung cancer that infused the research, clinical, and patient communities 12 years ago...

NCI Corner – Interview with Shakun Malik, MD

By Erik J. Mac Laren, PhD In late 2015, the US National Cancer Institute (NCI) Thoracic Malignancy Steering Committee (TMSC) published its strategic priorities for...

Meeting News